New cholesterol drug tested in people with kidney problems
NCT ID NCT07322016
First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This study looks at how a new cholesterol drug called HRS-1301 works in people with different levels of kidney function. Researchers want to see if the drug behaves differently in people with mild, moderate, or severe kidney problems compared to healthy people. The goal is to find the right dose for patients with kidney issues. About 36 adults aged 18 to 65 will take a single dose of the drug and be monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.